SA
Go ProLog In
DTIL
OverviewIntelligenceChart
Q3 2026 EPS Estimate
$-0.60
Reports before open
Revenue Estimate
$2M

Analyst Sentiment

Wall St. Consensus
Buy
12 analysts·Moderate coverage
69
Score
9 Buy (75%)3 Hold (25%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
975%
Hold
325%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$19.00
+162.8%
Consensus
$19.00
+162.8%
Bull
$19.00
+162.8%
12-Month Target Range12 analysts
$19.00$19.00$19.00
Current $7.23Consensus
Current Price
$7.23
Upside to Consensus
$11.77

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

No analyst estimates available

Earnings Surprises

Recent Analyst Actions

Mar 13, 2026Jefferies
Precision BioSciences Inc. (DTIL) PT Lowered to $19 at Jefferies, but 'near-term setup is attractive'
Target:$19.00
+235.1%from $5.67
Apr 1, 2024BTIG
Precision BioSciences price target raised to $30 from $2 at BTIG
Target:$30.00
+121.2%from $13.56
Nov 10, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Precision BioSciences, Lowers Price Target to $1
Target:$1.00
-27.5%from $1.38

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance